IE 11 is not supported. For an optimal experience visit our site on another browser.

Moderna CMO on peer review process for new Covid-19 vaccine


Dr. Tal Zaks commented on the peer review process Moderna's Covid-19 vaccine will undergo: "We are going to have the strongest peer review anybody could expect, which is a panel of experts looking deeply into the data, at an open panel the FDA will convene... the level of data and the level of rigor and the level of debate far outweighs what you generally see in a scientific publication."